Listed pharmas’ poor performances in 3rd quarter

Published: 2016-11-16 14:23:29

Updated: 2016-11-16 14:23:29

It was analyzed listed pharmaceutical companies had poor performances in the 3^rd quarter. Their sales were a little above the annual average, and the profitability was weakened compared to the last year.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the KOSPI and KOSDAQ listed pharmaceutical companies’ 2016 3^rd quarter performances, sales were increased by 5.2% compared t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.